FDA Adverse Event Injury Summary report: N

INTERMITTENT MAGIC3 HYDRO

MDR report key: 4963023 · Received July 31, 2015

Report

Report Number
1018233-2015-00243
Event Type
Injury
Date Received
July 31, 2015
Report Date
July 30, 2015
Manufacturer
ROCHESTER MEDICAL CORP.
Product Code
KOD
PMA / PMN Number
K000723
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETE, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVALUATION. THE DEVICE HISTORY RECORD WAS REVIEWED AND FOUND NOTHING THAT COULD HAVE CAUSED OR CONTRIBUTED TO THE REPORTED EVENT. THE INSTRUCTIONS FOR USE STATES THE FOLLOWING: "HOW TO PREPARE AND USE THE MAGIC 3 CATHETER. THE CATHETER IS INTENDED FOR URINARY BLADDER DRAINAGE IN PATIENTS REQUIRING CATHETERIZATION FOR MANAGEMENT OF INCONTINENCE, VOIDING DYSFUNCTION, AND SURGICAL PROCEDURES. THIS IS A SINGLE USE DEVICE. DO NOT REUSE. REUSE OF A SINGLE USE DEVICE INCREASES THE RISK OF CATHETER ACQUIRED URINARY TRACT INFECTIONS. URETHRAL CATHETER FOR UROLOGICAL USE ONLY. DISCARD AFTER USE. MADE OF SILICONE ELASTOMER." THE INFORMATION PROVIDED BY BARD REPRESENTS ALL OF THE KNOWN INFORMATION AT THIS TIME. DESPITE GOOD FAITH EFFORTS TO OBTAIN ADDITIONAL INFORMATION, THE COMPLAINANT / REPORTER WAS UNABLE OR UNWILLING TO PROVIDE ANY FURTHER PATIENT, PRODUCT, OR PROCEDURAL DETAILS TO BARD.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE CUSTOMER EXPERIENCED ECOLI IN THEIR BLADDER, URINE ODOR & ABDOMINAL PAIN AS A RESULT OF USING THE DEVICE. THE PATIENT WAS PRESCRIBED AN ANTIBIOTIC TO TREAT THE BLADDER PAIN. THE PATIENT HAS AN ADD'L DR'S VISIT SCHEDULED FOR (B)(6) 2015.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
499014 INTERMITTENT MAGIC3 HYDRO KOD ROCHESTER MEDICAL CORP. NA 56321279

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention